Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

Background: We assessed outcome of patients with moderate and severe COVID-19 following treatment with convalescent plasma (CP) and the association with IgG levels in transfused CP. Methods: A prospective cohort study. Primary outcome was improvement at day 14 defined as alive, not on mechanical ven...

Full description

Bibliographic Details
Main Authors: Yasmin Maor, Daniel Cohen, Nir Paran, Tomer Israely, Vered Ezra, Ofra Axelrod, Eilat Shinar, Marina Izak, Galia Rahav, Naomi Rahimi-Levene, Baruch M Bazofin, Ram Gelman, Dror Dicker, Tal Brosh-Nissimov, Orli Megged, David Dahan, Avi Benov, Alona Paz, Kaykov Edward, Amit Moran, Ori Rogowski, Patrick Sorkine, Ami Mayo, Oren Zimhony, Jacob Chen
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:EClinicalMedicine
Subjects:
Compassionate treatment
Moderate and Severe Covid19
Convalescent plasma
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020302698

Internet

http://www.sciencedirect.com/science/article/pii/S2589537020302698

Similar Items